血小板凝集設備市場（按產品類型、測試類型、方式和最終用戶分類）—2025-2032 年全球預測

預計到 2032 年，血小板凝集設備市場規模將成長至 22.2557 億美元，複合年成長率為 17.66%。

簡明易懂的介紹，概述了血小板凝集設備的現狀、關鍵技術以及相關人員的策略問題

血小板凝集設備領域正處於臨床需求與快速技術創新的交匯點，這主要源於對出血和血栓性疾病的及時診斷洞察日益成長的需求。臨床團隊、診斷實驗室和研究機構越來越需要能夠在各種醫療環境中（從集中式實驗室到分散式照護現場環境）提供可重複血小板功能測量的工具。為此，供應商正在加速跨多個平台的開發，結合微流體、光學和數據分析的進步，以提高吞吐量、使用者體驗和臨床可解釋性。

相關人員必須應對複雜的生態系統，其中包括傳統檢測設備、新興的盒式系統以及專為患者附近使用而設計的手持設備。監管預期和品質系統持續影響產品設計，而臨床實踐指南和支付管道則影響產品的採用。鑑於這些動態，決策者面臨的策略挑戰包括：如何平衡桌上型系統的資本投資與可攜式設備的操作靈活性，如何根據歷史標準檢驗新型檢測模式，以及如何建立夥伴關係以降低供應風險並促進臨床應用。本輪應用研究匯集了這些促進因素，並為更深入地探討變革趨勢、關稅影響、特定細分市場的促進因素以及決定未來競爭優勢的區域模式奠定了基礎。

技術法規和供應鏈的變革將影響血小板凝集診斷和未來的臨床工作流程

技術微型化、自動化以及診斷與數位健康的融合正在推動血小板凝集檢測的變革。自動化平台正在減少操作人員的差異性並提高通量，而微型試劑盒和手持式分析儀正在擴大急診和門診環境中的檢測範圍，從而加快臨床決策。同時，分析化學和檢測方法的改進正在提高靈敏度和特異性，影響臨床醫師在抗血小板治療、手術全期風險和止血障礙背景下對血小板功能的解讀。

不斷變化的法規和對真實世界證據的日益重視也在重塑產品藍圖。開發部門正在投資上市後實驗室測試以及與電子健康記錄的互通性，以證明臨床效用並支持報銷案例。最近的市場動盪使供應鏈彈性成為一項策略重點，鼓勵對關鍵零件採取近岸外包和雙重採購策略。數據主導服務（例如雲端分析和機器學習解讀）正在成為差異化因素，使供應商能夠提供以結果為導向的提案，而不僅僅是提供設備。這些轉變的融合正在重塑競爭格局，有利於那些能夠整合檢驗的檢測方法、以用戶為中心的設備格式和強大的數據生態系統以提供可衡量的臨床和營運價值的公司。

美國關稅變化對血小板凝集系統設備採購和供應鏈彈性的累積影響

美國近期的關稅調整具有累積效應，其影響超越了單一價格的變化，並正在影響設備製造商和醫療保健買家的採購、採購順序和合規性考慮。關稅帶來的成本壓力促使製造商重新評估材料清單決策，並優先考慮面向製造的設計原則，以減少對受關稅影響組件的依賴。因此，醫院和實驗室的採購團隊正在重新調整其供應商評估，將到岸成本、前置作業時間波動和單一來源供應商的風險敞口納入考量。

這些關稅行動也加速了圍繞地域多元化和供應鏈彈性的討論。一些製造商正在將高價值的組裝和校準流程轉移到貿易條件優惠的司法管轄區，同時尋求策略性庫存緩衝和長期供應商協議以穩定價格。此外，這些措施還帶來了下游影響，例如在設備供應商與大型醫療系統之間的合約談判中，企業將重新關注總體擁有成本和服務水準保證。此外，合規團隊正在加強對海關分類和文件記錄實務的審查，以降低審核風險。總而言之，這些因素正在重新定義企業如何規劃資本採購、發展供應商關係，以及如何優先投資於能夠適應不斷變化的貿易政策的模組化或可擴展產品架構。

分段情報揭示產品類型、測試方法、分析格式、最終用戶特徵等如何改變採購和開發選擇

細緻的細分視角闡明了需求促進因素，並描述了涵蓋產品架構、分析模式、使用方式和最終用戶需求的針對性打入市場策略。產品類型分為桌上型儀器（優先考慮通量、整合工作流程和進階分析）和可攜式儀器（強調快速週轉、簡化操作和照護現場部署）。流式細胞技術本身分為測量血小板標記的直接流式細胞技術應用和評估血小板活化模式的功能性流式細胞技術評估。阻抗凝集素測定分為富血小板血漿電阻和全血電阻兩種形式，它們在分析前要求和臨床便利性方面有所不同。透光凝集素測定涵蓋光密度和電阻測定，這兩種測定是許多臨床方案的參考標準。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

• 介紹一種用於照護現場心臟風險評估的可攜式微流體血小板凝集儀
• 人工智慧驅動的影像分析演算法在快速診斷血小板凝集試驗中的整合
• 門診一次性血小板功能檢查試劑盒的研製
• 黏彈性測試平台的興起將補充手術監測中傳統的透光性
• 引入雲端基礎的資料管理系統，簡化跨多個機構的血小板凝集檢測工作流程

第6章 2025年美國關稅的累積影響

第7章 人工智慧的累積影響，2025年

第 8 章血小板凝集設備市場（依產品類型）

• 桌上型裝置
• 可攜式設備

第9章血小板凝集設備市場（依測試類型）

• 流式細胞技術
  • 直接流式細胞技術
  • 功能性流式細胞技術
• 電阻檢測法
  • 富血小板血漿電阻
  • 全血電阻
• 透光性聚集度測量
  • 光密度測定
  • 比濁法

第 10 章血小板凝集設備市場（按模式）

• 體外試驗
  • 聚集測量系統
  • 電阻系統
• 照護現場系統
  • 基於墨盒的系統
  • 手持裝置

第 11 章血小板凝集設備市場（按最終用戶）

• 學術機構
  • 教學醫院
  • 大學
• 診斷實驗室
  • 中央實驗室
  • 照護現場實驗室
• 醫院
  • 社區醫院
  • 三級醫療機構
• 研究所
  • 生技公司
  • 製藥公司

第12章血小板凝集設備市場（按地區）

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第13章血小板凝集設備市場：依類別

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第14章血小板凝集設備市場（依國家）

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第15章競爭格局

• 2024年市佔率分析
• 2024年FPNV定位矩陣
• 競爭分析
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Werfen Life Science SLU
  • Diagnostica Stago SAS
  • DiaMed AG
  • Helena Laboratories Corporation
  • Sienco Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Haemonetics Corporation

The Platelet Aggregation Devices Market is projected to grow by USD 2,225.57 million at a CAGR of 17.66% by 2032.

A clear concise introduction outlining the current platelet aggregation device landscape key technologies and strategic questions for stakeholders

The landscape of platelet aggregation devices sits at the intersection of clinical necessity and rapid technological innovation, driven by rising demand for timely diagnostic insight into bleeding and thrombotic disorders. Clinical teams, diagnostic laboratories, and research organizations increasingly require tools that deliver reproducible platelet function measurements across diverse care settings, from centralized laboratories to decentralized point-of-care environments. In response, vendors have accelerated development across multiple platforms, combining advances in microfluidics, optics, and data analytics to improve throughput, user experience, and clinical interpretability.

Stakeholders must navigate a complex ecosystem that includes legacy laboratory instruments, emergent cartridge-based systems, and portable handheld devices designed for near-patient use. Regulatory expectations and quality systems continue to shape product design, while clinical practice guidelines and payor pathways influence adoption. Given these dynamics, strategic questions for decision-makers include how to balance capital investment in benchtop systems with the operational flexibility of portable instruments, how to validate novel test modalities against historical standards, and how to structure partnerships that de-risk supply and accelerate clinical adoption. This introduction synthesizes those drivers and sets the stage for a deeper examination of transformative trends, tariff implications, segmentation-specific dynamics, and regional patterns that will determine competitive advantage going forward.

Transformative technological regulatory and supply chain shifts reshaping platelet aggregation diagnostics and future clinical workflows

Technological miniaturization, automation, and the convergence of diagnostics with digital health are creating transformative shifts across platelet aggregation testing. Automated platforms are reducing operator variability and accelerating throughput, while miniaturized cartridges and handheld analyzers extend testing into acute care and ambulatory settings, enabling faster clinical decisions. Concurrently, enhancements in assay chemistry and detection modalities are improving sensitivity and specificity, which in turn affects how clinicians interpret platelet function in the context of antiplatelet therapy, perioperative risk, and hemostatic disorders.

Regulatory evolution and the increasing emphasis on real-world evidence are also reshaping product roadmaps. Developers are investing in post-market clinical studies and interoperability with electronic health records to demonstrate clinical utility and support reimbursement conversations. Supply chain resilience has become a strategic priority following recent disruptions, encouraging nearshoring of critical components and dual-sourcing strategies. Data-driven services, including cloud-enabled analytics and machine learning-assisted interpretation, are becoming differentiators, enabling vendors to offer outcomes-oriented propositions rather than standalone instruments. These converging shifts are reconfiguring competitive dynamics, favoring organizations that can integrate validated assays, user-centric device formats, and robust data ecosystems to deliver measurable clinical and operational value.

Cumulative effects of revised United States tariffs on device sourcing procurement and supply chain resilience for platelet aggregation systems

Recent tariff adjustments in the United States have produced a cumulative set of effects that extend beyond discrete price changes, influencing sourcing, procurement cadence, and compliance considerations for device manufacturers and institutional buyers. Tariff-driven cost pressures are prompting manufacturers to reevaluate bill-of-materials decisions and to prioritize design-for-manufacture principles that reduce reliance on tariff-exposed components. In turn, procurement teams at hospitals and laboratories are recalibrating supplier evaluations to include landed cost sensitivity, lead-time variability, and risk exposure from single-source vendors.

These tariff dynamics also accelerate conversations about geographic diversification and supply chain resilience. Some manufacturers are shifting higher-value assembly and calibration steps to jurisdictions with favorable trade terms, while others pursue strategic inventory buffers and longer-term supplier agreements to stabilize pricing. There are downstream implications for contract negotiations between device suppliers and large health systems, with renewed focus on total cost of ownership and service-level guarantees. Moreover, compliance teams are intensifying scrutiny of customs classification and documentation practices to mitigate audit risk. Collectively, these factors are redefining how organizations plan capital purchases, structure supplier relationships, and prioritize investments in modular or scalable product architectures that can adapt to evolving trade policies.

Segment-specific intelligence revealing how product types test modalities assay formats and end-user characteristics are reshaping procurement and development choices

A nuanced segmentation lens clarifies demand drivers and informs targeted go-to-market strategies across product architecture, analytical modality, modality of use, and end-user needs. Based on product type, the landscape bifurcates between benchtop instruments that prioritize throughput, integrated workflows, and advanced analytics, and portable instruments that emphasize rapid turnaround, simplified operation, and deployment at point of care. Based on test type, the universe of assays includes flow cytometry approaches and aggregometry techniques; flow cytometry itself divides into direct flow cytometry applications that measure platelet markers and functional flow cytometry assessments that evaluate platelet activation patterns, while impedance aggregometry separates into platelet rich plasma impedance methods and whole blood impedance formats that differ in pre-analytical requirements and clinical convenience, and light transmission aggregometry spans optical density assays and turbidimetric assays that remain reference standards in many clinical protocols.

Based on modality, in vitro assays encompass both aggregometry systems and impedance systems used in centralized laboratories, whereas point of care systems are increasingly represented by cartridge-based systems and handheld devices enabling decentralization. Based on end user, adoption and purchasing behavior vary across academic institutions, diagnostic laboratories, hospitals, and research institutes; academic institutions split into teaching hospitals and universities that combine education with clinical demand, diagnostic laboratories differentiate between central laboratories and point-of-care laboratories with distinct workflow and regulatory profiles, hospitals range from community hospitals with constrained resources to tertiary hospitals with complex case mix, and research institutes include biotechnology firms and pharmaceutical companies focused on translational studies and drug development. Interpreting these segment distinctions within a cohesive strategy supports tailored product development, clinical validation plans, and customer engagement models that reflect heterogeneous operational realities.

Regional competitive dynamics across the Americas Europe Middle East and Africa and Asia-Pacific shaping adoption distribution and reimbursement strategies

Geographic dynamics materially influence adoption pathways, reimbursement environments, and competitive positioning in the platelet aggregation devices space. In the Americas, clinical demand often centers on rapid adoption where reimbursement infrastructure and consolidated health systems can facilitate scale deployments, while supply chain proximity to manufacturing hubs remains a competitive advantage for vendors. In Europe, Middle East & Africa, regulatory harmonization across jurisdictions and heterogeneous reimbursement policies create a patchwork of market entry considerations that require localized regulatory strategies and partnerships with regional distributors. In Asia-Pacific, fast-growing clinical research capacity and diversified manufacturing ecosystems support both rapid deployment of new modalities and competitive cost structures; however, market access strategies must account for varying clinical guidelines, reimbursement mechanisms, and procurement cycles across countries.

Across regions, differences in laboratory infrastructure, clinician training, and hospital procurement governance shape product specifications and service models. For example, institutions in resource-constrained settings may prioritize ruggedized, low-maintenance portable systems and simplified assays, whereas tertiary centers favor high-throughput benchtop platforms with advanced analytics. Distribution networks, local regulatory timelines, and trends toward regional manufacturing also affect time to adoption. Therefore, a finely differentiated regional playbook-aligned with clinical needs, reimbursement realities, and distribution capabilities-is essential for organizations seeking sustainable growth and operational resilience in global markets.

Strategic company-level analysis illuminating competitive positioning technology roadmaps go-to-market approaches and partnership strategies in platelet diagnostics

Competitive dynamics among companies in the platelet aggregation devices sector are driven by a combination of technology differentiation, quality systems maturity, strategic partnerships, and execution on clinical evidence. Leading firms focus on expanding their intellectual property around assay chemistries, detection modules, and data interpretation algorithms, while also investing in regulatory pathways that provide clear claims for intended use. Collaboration with clinical research centers and incorporation of user feedback into design iterations remain central to reducing clinical friction and accelerating adoption. In parallel, companies that secure robust supply chains and scalable manufacturing footprints position themselves to respond to demand volatility and to meet large institutional contracts.

Go-to-market strategies vary from direct sales to distributor-led models, with many organizations adopting hybrid approaches to balance control and market reach. Strategic partnerships, including co-development agreements with diagnostics labs or licensing arrangements with reagent suppliers, can shorten time to market and extend product portfolios. Additionally, after-sales service models and training programs increasingly contribute to differentiation, especially in complex hospital environments where uptime and support drive purchasing decisions. Investors and corporate development teams are monitoring consolidation activity and bolt-on acquisitions as mechanisms to acquire niche capabilities, expand geographic coverage, or integrate complementary assay technologies into integrated platforms.

Actionable strategic recommendations for leaders to balance supply resilience product modularity clinical evidence and commercial models to capture sustainable value

To convert insight into advantage, industry leaders should adopt a multi-pronged strategy that balances near-term operational resilience with long-term product differentiation. First, diversify component sourcing and consider regionalized manufacturing for critical subassemblies to mitigate tariff and logistics exposure while preserving unit economics. Second, prioritize modular product architectures that allow platforms to support both centralized laboratory workflows and point-of-care applications through interchangeable assay cartridges or software configurations, which preserves R&D investments and expands addressable use cases.

Third, invest in clinical evidence generation that targets high-impact use cases and payer-relevant outcomes, leveraging pragmatic studies and real-world data to strengthen value propositions. Fourth, accelerate digital integration by developing interoperability with electronic health records and enabling cloud-based analytics that support clinician decision-making and health system reporting. Fifth, structure commercial models to include flexible financing, managed service agreements, and training programs that lower adoption barriers for hospital systems and laboratories. Finally, pursue selective partnerships and acquisitions that complement core competencies-whether in assay chemistry, manufacturing scale, or distribution reach-to expedite time to market and broaden service offerings. These actions together foster resilience, enhance clinical adoption, and create differentiated, defensible product strategies.

Transparent research methodology detailing stakeholder engagements data triangulation analytical frameworks and validation protocols used to develop the report

The research underpinning these insights synthesizes a systematic mix of primary engagements and rigorous secondary analysis, structured to ensure reproducibility and transparency. Primary research included structured interviews with clinical laboratory directors, hospital procurement leads, regulatory specialists, and R&D heads at device manufacturers, providing firsthand perspectives on clinical utility, operational constraints, and procurement priorities. Secondary inputs consisted of peer-reviewed literature on assay performance, regulatory submissions and clearances, technical white papers, and product literature to triangulate device capabilities and differentiation points.

Analytical methods encompassed comparative feature mapping, supply chain mapping to identify sourcing risks, and scenario analysis to evaluate the impact of trade and regulatory shifts on procurement behavior. Validation steps involved cross-checking interview findings with documented clinical practice guidelines and with anonymized feedback from end users who piloted devices. Quality control protocols ensured consistency in terminology, device categorization, and inclusion criteria for products and assays. Wherever possible, findings were corroborated across multiple sources to reduce bias and to produce a robust evidence base for the recommendations and regional insights presented in this report.

Concluding synthesis integrating technology regulatory and regional insights to guide executive decision-making in platelet aggregation diagnostics

In synthesis, the platelet aggregation device landscape is undergoing rapid evolution as technological advances converge with shifting regulatory expectations and supply chain realignments. The interplay between benchtop and portable instruments, the diversity of assay modalities including flow cytometry, impedance and light transmission techniques, and the growing prominence of point-of-care formats collectively reshape clinical pathways and procurement decisions. Regional heterogeneity in reimbursement, regulatory frameworks, and infrastructure further underscores the need for differentiated commercial strategies and technical adaptability.

For decision-makers, the imperative is clear: invest in adaptable platforms that can span laboratory and near-patient settings, build the clinical evidence that resonates with payers and clinicians, and structure resilient supply chains to buffer policy and trade volatility. Companies that deliver integrated solutions-combining validated assays, seamless data integration, and robust service models-will have the strategic advantage. Ultimately, coherent alignment between product design, clinical validation, and targeted regional go-to-market execution will determine which organizations capture enduring value in this rapidly changing domain.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Emergence of portable microfluidic platelet aggregometers for point-of-care cardiac risk assessment
• 5.2. Integration of AI-driven image analysis algorithms in platelet aggregation assays for rapid diagnostics
• 5.3. Development of single-use disposable cartridges enabling decentralized platelet function testing in outpatient settings
• 5.4. Rise of viscoelastic testing platforms to complement traditional light transmission platelet aggregation devices in surgical monitoring
• 5.5. Adoption of cloud-based data management systems to streamline multi-site platelet aggregation study workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Platelet Aggregation Devices Market, by Product Type

• 8.1. Benchtop Instruments
• 8.2. Portable Instruments

9. Platelet Aggregation Devices Market, by Test Type

• 9.1. Flow Cytometry
  • 9.1.1. Direct Flow Cytometry
  • 9.1.2. Functional Flow Cytometry
• 9.2. Impedance Aggregometry
  • 9.2.1. Platelet Rich Plasma Impedance
  • 9.2.2. Whole Blood Impedance
• 9.3. Light Transmission Aggregometry
  • 9.3.1. Optical Density Assays
  • 9.3.2. Turbidimetric Assays

10. Platelet Aggregation Devices Market, by Modality

• 10.1. In Vitro Assays
  • 10.1.1. Aggregometry Systems
  • 10.1.2. Impedance Systems
• 10.2. Point Of Care Systems
  • 10.2.1. Cartridge-Based Systems
  • 10.2.2. Handheld Devices

11. Platelet Aggregation Devices Market, by End User

• 11.1. Academic Institutions
  • 11.1.1. Teaching Hospitals
  • 11.1.2. Universities
• 11.2. Diagnostic Laboratories
  • 11.2.1. Central Laboratories
  • 11.2.2. Point-Of-Care Laboratories
• 11.3. Hospitals
  • 11.3.1. Community Hospitals
  • 11.3.2. Tertiary Hospitals
• 11.4. Research Institutes
  • 11.4.1. Biotechnology Firms
  • 11.4.2. Pharmaceutical Companies

12. Platelet Aggregation Devices Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Platelet Aggregation Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Platelet Aggregation Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Siemens Healthineers AG
  • 15.3.2. Sysmex Corporation
  • 15.3.3. Werfen Life Science SLU
  • 15.3.4. Diagnostica Stago SAS
  • 15.3.5. DiaMed AG
  • 15.3.6. Helena Laboratories Corporation
  • 15.3.7. Sienco Inc.
  • 15.3.8. Bio/Data Corporation
  • 15.3.9. F. Hoffmann-La Roche AG
  • 15.3.10. Haemonetics Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. PLATELET AGGREGATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PORTABLE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIRECT FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY FUNCTIONAL FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PLATELET RICH PLASMA IMPEDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY WHOLE BLOOD IMPEDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY OPTICAL DENSITY ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TURBIDIMETRIC ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY AGGREGOMETRY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CARTRIDGE-BASED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CENTRAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY TERTIARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 207. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 208. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 209. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 210. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 211. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 212. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 213. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
• TABLE 214. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
• TABLE 215. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 216. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 217. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 218. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 219. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 220. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 221. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
• TABLE 222. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2032 (USD MILLION)
• TABLE 223. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 224. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 225. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 226. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 227. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
• TABLE 228. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2032 (USD MILLION)
• TABLE 229. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
• TABLE 230. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
• TABLE 231. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 232. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 233. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
• TABLE 234. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
• TABLE 235. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 236. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 237. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 238. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 239. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 240. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 241. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
• TABLE 242. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
• TABLE 243. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 244. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 245. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 246. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 247. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 248. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 249. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
• TABLE 250. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2032 (USD MILLION)
• TABLE 251. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 252. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 253. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 255. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
• TABLE 256. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2032 (USD MILLION)
• TABLE 257. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
• TABLE 258. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
• TABLE 259. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 260. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 261. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
• TABLE 262. NORTH AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
• TABLE 263. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 266. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 267. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 268. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 269. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
• TABLE 270. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
• TABLE 271. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 272. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IMPEDANCE AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 273. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2018-2024 (USD MILLION)
• TABLE 274. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY LIGHT TRANSMISSION AGGREGOMETRY, 2025-2032 (USD MILLION)
• TABLE 275. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 276. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 277. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2018-2024 (USD MILLION)
• TABLE 278. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY IN VITRO ASSAYS, 2025-2032 (USD MILLION)
• TABLE 279. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 280. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY POINT OF CARE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 281. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 282. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 283. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
• TABLE 284. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2032 (USD MILLION)
• TABLE 285. LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
• TABLE 286. LATIN AMERICA PLATELET AGGREGATION DEVI